Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05709626
PHASE4
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
Sponsor: Kindai University
View on ClinicalTrials.gov
Summary
The aim of this study is to evaluate the safety of prasugrel monotherapy without aspirin versus 12-month dual antiplatelet therapy (DAPT) in patients with STEMI using platinum-chrome everolimus-eluting stent (PtCr-EES: SYNERGYTM).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2258
Start Date
2023-02-28
Completion Date
2028-01-04
Last Updated
2023-03-01
Healthy Volunteers
No
Interventions
DRUG
No aspirin (Prasugurel monotherapy)
12-month prasugrel monotherapy
DRUG
12-month DAPT
12-month dual antiplatelet therapy with prasugrel and aspirin
Locations (1)
Kindai University Faculty of Medicine
Sayama, Osaka, Japan